[The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles]. 1990

L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia

The results of 5-year observations on the duration of immunity to measles virus in persons vaccinated and revaccinated against measles, as well as in persons having had this infection, are presented. The intensity of immunity was determined in the same persons with the use of the passive hemagglutination test. The study revealed differences in the formation, intensity and duration of postvaccinal immunity. A significant decrease in the concentration of antibodies over the period of 5 years was established in 50.0-52.3% of vaccines. Revaccination with live measles vaccine is an effective measure for enhancing immunity to measles virus in persons with initial antibody titers less than 1:10-1:20, but revaccination made in a single injection is not sufficient for the stable maintenance of measles morbidity at the sporadic level. Postinfectious immunity is characterized by stability and has no tendency towards decrease. Persons having had measles have no need in additional measures irrespective of the time elapsed after the disease.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003289 Convalescence The period of recovery following an illness. Convalescences
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
June 1978, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
October 1974, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
January 1970, Revista do Hospital das Clinicas,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
January 1989, Lijecnicki vjesnik,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
January 1965, Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
January 1954, Bulletin of the World Health Organization,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
January 1985, Trudy Instituta imeni Pastera,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
August 1966, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
November 1962, Voprosy okhrany materinstva i detstva,
L I Sliusar', and A A Sokhin, and F S Radomskaia, and G V Degtiareva, and L I Panasenko, and T P Litvinova, and R V Komarevskaia, and Zh I Bol'shinskaia
April 1967, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!